Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery

International Journal of Pharmaceutics

Volumn 489, Issue 1-2, 2015, Pages 1-10

  Cosco, Donato ^a   Paolino, Donatella ^a   Maiuolo, Jessica ^a   Marzio, Luisa Di ^b   Carafa, Maria ^c   Ventura, Cinzia A ^d   Fresta, Massimo ^a  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Multi drug colloidal carriers; Skin cancer; Skin delivery; Supramolecular therapeutics; Ultradeformable liposomes

Indexed keywords

FLUOROURACIL; LIPOSOME; RESVERATROL; ANTINEOPLASTIC AGENT; STILBENE DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CELL VIABILITY; COMET ASSAY; CONTROLLED STUDY; DNA FRAGMENTATION; DNA STRAND BREAKAGE; DRUG RELEASE; ENCAPSULATION; EPIDERMIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPOSOMAL DELIVERY; NON MELANOMA SKIN CANCER; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; STRATUM CORNEUM; TUNEL ASSAY; CELL SURVIVAL; CUTANEOUS DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; SKIN; SKIN ABSORPTION; SKIN NEOPLASMS; TUMOR CELL LINE;

ADMINISTRATION, CUTANEOUS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL SURVIVAL; FLUOROURACIL; HUMANS; IN VITRO TECHNIQUES; LIPOSOMES; SKIN; SKIN ABSORPTION; SKIN NEOPLASMS; STILBENES;

EID: 84928566646     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.04.056     Document Type: Article

References (43)

1. D. Ainbinder, D. Paolino, M. Fresta, and E. Touitou Drug delivery applications with ethosomes J. Biomed. Nanotechnol. 6 2010 558 568
2. F. Amiri, A.H. Zarnani, H. Zand, F. Koohdani, M. Jeddi-Tehrani, and M. Vafa Synergistic anti-proliferative effect of resveratrol and etoposide on human hepatocellular and colon cancer cell lines Eur. J. Pharmacol. 718 2013 34 40
3. H.A. Benson Transfersomes for transdermal drug delivery Expert Opin. Drug Deliv. 3 2006 727 737
4. J.P. Cai, W. Chen, X. Hou, L.J. Liang, X.Y. Hao, and X.Y. Yin Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism Anticancer Drugs 24 2013 1020 1029
5. C. Celia, F. Cilurzo, E. Trapasso, D. Cosco, M. Fresta, and D. Paolino Ethosomes® and transfersomes® containing linoleic acid: physicochemical and technological features of topical drug delivery carriers for the potential treatment of melasma disorders Biomed. Microdevices 14 2012 119 130
6. C. Celia, E. Trapasso, D. Cosco, D. Paolino, and M. Fresta Turbiscan lab expert analysis of the stability of ethosomes and ultradeformable liposomes containing a bilayer fluidizing agent Colloids Surf. B 72 2009 155 160
7. G. Cevc, and G. Blume New highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes Biochim. Biophys. Acta 1514 2001 191 205
8. G. Cevc, and U. Vierl Nanotechnology and the transdermal route: a state of the art review and critical appraisal J. Controlled Release 141 2010 277 299
9. G. Cevc Lipid vesicles and other colloids as drug carriers on the skin Adv. Drug Deliv. Rev. 56 2004 675 711
10. G. Cevc Transdermal drug delivery of insulin with ultradeformable carriers Clin. Pharmacokinet. 42 2003 461 474
11. J.Y. Chan, M.S. Phoo, M.V. Clement, S. Pervaiz, and S.C. Lee Resveratrol displays converse dose-related effects on 5-fluorouracil-evoked colon cancer cell apoptosis: the roles of caspase-6 and p53 Cancer Biol. Ther. 7 2008 1305 1312
12. D. Cosco, C. Celia, F. Cilurzo, E. Trapasso, and D. Paolino Colloidal carriers for the enhanced delivery through the skin Expert Opin. Drug Deliv. 5 2008 737 755
13. D. Cosco, D. Paolino, F. Cilurzo, F. Casale, and M. Fresta Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases Int. J. Pharm. 422 2012 229 237
14. D. Cosco, D. Paolino, J. Maiuolo, D. Russo, and M. Fresta Liposomes as multicompartimental carriers for the multidrug delivery in anticancer chemotherapy Drug Deliv. Transl. Res. 1 2011 66 75
15. A. Dicko, L.D. Mayer, and P.G. Tardi Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo Expert Opin. Drug Deliv. 7 2010 1329 1341
16. Y.B. Dong, H.L. Yang, M.J. Elliott, and K.M. McMasters Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors Cancer Res. 62 2002 1776 1783
17. G.M. El Zaafarany, G.A. Awad, S.M. Holayel, and N.D. Mortada Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery Int. J. Pharm. 397 2010 164 172
18. M.M. Elsayed, O.Y. Abdallah, V.F. Naggar, and N.M. Khalafallah Deformable liposomes and ethosomes as carriers for skin delivery of ketotifen Pharmazie 62 2007 133 137
19. M.M. Elsayed, O.Y. Abdallah, V.F. Naggar, and N.M. Khalafallah Lipid vesicles for skin delivery of drugs: reviewing three decades of research Int. J. Pharm. 332 2007 1 16
20. C. Filgueiras Mde, A. Morrot, P.M. Soares, M.L. Costa, and C. Mermelstein Effects of 5-fluorouracil in nuclear and cellular morphology, proliferation, cell cycle, apoptosis, cytoskeletal and caveolar distribution in primary cultures of smooth muscle cells PLoS One 8 2013 e63177
21. M.P. Fuggetta, S. D'Atri, G. Lanzilli, M. Tricarico, E. Cannavò, G. Zambruno, R. Falchetti, and G. Ravagnan In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide Melanoma Res. 14 2004 189 196
22. G. Gatouillat, E. Balasse, D. Joseph-Pietras, H. Morjani, and C. Madoulet Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma J. Cell. Biochem. 110 2010 893 902
23. A. González-Paredes, M. Manconi, C. Caddeo, A. Ramos-Cormenzana, M. Monteoliva-Sánchez, and A.M. Fadda Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study J. Liposome Res. 20 2010 269 276
24. K. Gross, L. Kircik, and G. Kricorian 5% 5-Fluorouracil cream for the treatment of small superficial basal cell carcinoma: efficacy tolerability, cosmetic outcome, and patient satisfaction Dermatol. Surg. 33 2007 433 439
25. G. Haroske, J.P. Baak, H. Danielsen, F. Giroud, A. Gschwendtner, M. Oberholzer, A. Reith, P. Spieler, and A. Böcking Fourth updated ESACP consensus report on diagnostic DNA image cytometry Anal. Cell. Pathol. 23 2001 89 95
26. P.M. Hwang, F. Bunz, J. Yu, C. Rago, T.A. Chan, and M.P. Murphy Ferredoxin reductase affects p53-dependent: 5-fluorouracil-induced apoptosis in colorectal cancer cells Nat. Med. 7 2001 1111 1117
27. S. Jain, R. Sapre, A.K. Tiwary, and N.K. Jain Proultraflexible lipid vesicles for effective transdermal delivery of levonorgestrel: development characterization, and performance evaluation AAPS PharmSciTech 6 2005 E513 522
28. Y.H. Kim, S.W. Shin, B.S. Kim, J.H. Kim, J.G. Kim, Y.J. Mok, C.S. Kim, H.S. Rhyu, J.H. Hyun, and J.S. Kim Paclitaxel 5-fluorouracil, and cisplatin combination chemotherapy for the treatment of advanced gastric carcinoma Cancer 85 1999 295 301
29. A.M. Kligman, and E. Christophers Preparation of isolated sheets of human stratum corneum Arch. Dermatol. 88 1963 702 705
30. T. Kubota, Y. Uemura, M. Kobayashi, and H. Taguchi Combined effects of resveratrol and paclitaxel on lung cancer cells Anticancer Res. 23 2003 4039 4346
31. C. Marianecci, F. Rinaldi, M. Mastriota, S. Pieretti, E. Trapasso, D. Paolino, and M. Carafa Anti-inflammatory activity of novel ammonium glycyrrhizinate/niosomes delivery system: human and murine models J. Controlled Release 164 2012 17 25
32. M. Palumbo, A. Russo, V. Cardile, M. Renis, D. Paolino, G. Puglisi, and M. Fresta Improved antioxidant effect of idebenone-loaded polyethyl-2-cyanoacrylate nanocapsules tested on human fibroblasts Pharm. Res. 19 2002 71 78
33. D. Paolino, D. Cosco, F. Cilurzo, E. Trapasso, V.M. Morittu, C. Celia, and M. Fresta Improved in vitro and in vivo collagen biosynthesis by asiaticoside-loaded ultradeformable vesicles J. Controlled Release 162 2012 143 151
34. D. Paolino, D. Cosco, R. Muzzalupo, E. Trapasso, N. Picci, and M. Fresta Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer Int. J. Pharm. 353 2008 233 242
35. S. Ramaswamy Rational design of cancer-drug combinations N. Engl. J. Med. 357 2007 299 300
36. A. Saija, A. Tomaino, D. Trombetta, A. De Pasquale, N. Uccella, T. Barbuzzi, D. Paolino, and F. Bonina In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents Int. J. Pharm. 199 2000 39 47
37. R.A. Schwendener, and H. Schott Liposome formulations of hydrophobic drugs Methods Mol. Biol. 605 2010 129 138
38. S. Singh, R. Davis, V. Alamanda, R. Pireddu, D. Pernazza, S. Sebti, N. Lawrence, and S. Chellappan Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine Mol. Cancer Ther. 9 2010 3330 3341
39. C. Sinico, and A.M. Fadda Vesicular carriers for dermal drug delivery Expert Opin. Drug Deliv. 6 2009 813 825
40. P.G. Tardi, N. Dos Santos, T.O. Harasym, S.A. Johnstone, N. Zisman, A.W. Tsang, D.G. Bermudes, and L.D. Mayer Drug ratio-dependent antitumor activity of irinotecan and cisplatin combinations in vitro and in vivo Mol. Cancer Ther. 8 2009 2266 2275
41. P.G. Tardi, R.C. Gallagher, S. Johnstone, N. Harasym, M. Webb, M.B. Bally, and L.D. Mayer Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo Biochim. Biophys. Acta 1768 2007 678 687
42. N.A. Thornberry, and Y. Lazebnik Caspases: enemies within Science 281 1998 1312 1316
43. T. Yin, P. Wang, J. Li, Y. Wang, B. Zheng, R. Zheng, D. Cheng, and X. Shuai Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes Biomaterials 35 2014 5932 5943